Insider Trading & Ownership - KOCH KEVIN

Real time insider trading transaction history:

  • Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Insider Trading Transactions for KOCH KEVIN
Common stock purchase or sale:
Transaction
Date
Reported
DateTime
CompanySymbolInsider
Relationship
Shares
Traded
Average
Price
Total
Amount
Shares
Owned
Filing
2024-05-02
Sale
2024-05-03
6:26 pm
Edgewise Therapeutics Inc.EWTXKOCH KEVIN
President and CEO
3,152$18.91$59,604363,679
(Indirect
Direct)
View
2023-05-02
Sale
2023-05-03
6:25 pm
Edgewise Therapeutics Inc.EWTXKOCH KEVIN
President and CEO
3,203$8.9049$28,522366,831
(Indirect
Direct)
View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
CompanySymnbolInsider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing
2024-08-12
Option Award
2024-08-14
4:14 pm
N/A
2034-08-12
Edgewise Therapeutics Inc.EWTXKOCH KEVIN
President and CEO
503,125$0503,125
(Direct)
View
2024-05-01
Exercise
2024-05-03
6:26 pm
N/A
2032-05-01
Edgewise Therapeutics Inc.EWTXKOCH KEVIN
President and CEO
10,417$0363,679
(Direct)
View
2023-08-17
Option Award
2023-08-18
7:12 pm
N/A
2033-08-17
Edgewise Therapeutics Inc.EWTXKOCH KEVIN
President and CEO
600,000$0600,000
(Direct)
View
2023-05-01
Exercise
2023-05-03
6:25 pm
N/A
2032-05-01
Edgewise Therapeutics Inc.EWTXKOCH KEVIN
President and CEO
10,416$0366,831
(Direct)
View
2022-08-08
Option Award
2022-08-10
5:41 pm
N/A
2032-08-08
Edgewise Therapeutics Inc.EWTXKOCH KEVIN
President and CEO
550,000$0550,000
(Direct)
View
2022-05-01
Option Award
2022-05-03
4:14 pm
N/A
2025-05-01
Edgewise Therapeutics Inc.EWTXKOCH KEVIN
President and CEO
31,250$031,250
(Direct)
View
2021-08-17
Option Award
2021-08-19
5:09 pm
N/A
2031-08-17
Edgewise Therapeutics Inc.EWTXKOCH KEVIN
President and CEO
400,000$0400,000
(Direct)
View

Ownership
2021-03-25
9:38 pm
N/A
N/A
Edgewise Therapeutics Inc.EWTXKOCH KEVIN
President and CEO
0$02,105,104
(Indirect)
View
2020-05-21
Option Award
2020-05-22
5:16 pm
N/A
2030-05-20
MIRAGEN THERAPEUTICS INC.MGENKOCH KEVIN
Director
24,000$024,000
(Direct)
View